Do we start with GLP-1
Tronieri JS, Wadden TA, Walsh OA, Berkowitz RI, Alamuddin N, Gruber K, et al
It absorbs quickly and doesnt leave that sticky or coated feeling that so many body lotions do
The data were, however, not compatible with a protective intention-to-treat effect. They concluded: Randomized trials using MALO as an outcome might be unfeasible, motivating further large observational studies using appropriate methodology to further delineate the effect of GLP1 agonists on the risk of MALO, complementing future phase 3 trials of GLP1 agonists.
HK Vanyai was supported by the Al & Val Rosenstrauss Fellowship from the Rebecca L
As a result, patients often draw up a certain number of units that correspond to a specific milligram dose based on the medication concentration